Recomec

Recomec functions as a private investment holding company, strategically deploying capital into high-growth enterprises. It primarily acquires stakes in innovative companies across life sciences, digital health, and advanced technology. Providing patient capital and strategic guidance, Recomec fosters portfolio development generating substantial long-term value.

The Zanelli family, prominent Italian entrepreneurs, established Recomec. After successfully owning and divesting Comecer Spa, a leading manufacturer of nuclear medicine and pharmaceutical production systems, the family founded this holding. Their insight channeled accumulated capital and seasoned industrial acumen into new ventures.

Recomec's portfolio companies, including biotech innovators like CellPly and digital health platforms such as Medendi, are its direct partners. These enterprises leverage Recomec's financial backing and strategic oversight to scale operations and advance missions. Its vision is to cultivate a diverse ecosystem of pioneering businesses, supporting disruptive technologies and sustainable growth.